To explore the mechanisms by which METTL14-mediated m6A modification regulates breast cancer stemness, we performed methylated RNA immunoprecipitation (MeRIP) sequencing using MCF7 cells, in which METTL14 is highly expressed. Here, METTL14 is linked to breast cancer.